Alemtuzumab


MabCampath 30 mg/ml concentrate for solution for infusion

MabCampath is used to treat patients with chronic lymphocytic leukaemia (CLL), a cancer of the lymphocytes (a type of white blood cell). It is used in patients for whom treatment combinations including fludarabine (another medicine used in leukaemia) are not appropriate.The active substance in... Mehr

Producer: Genzyme Europe B.V.

Therapeutic group: Antineoplastic agents


MabCampath 10 mg/ml concentrate for solution for infusion

MabCampath is used to treat patients with chronic lymphocytic leukaemia (CLL), a cancer of the lymphocytes (a type of white blood cell). It is used in patients for whom treatment combinations including fludarabine (another medicine used in leukaemia) are not appropriate.The active substance in... Mehr

Producer: Genzyme Europe B.V.

Therapeutic group: Antineoplastic agents


Cookies help us deliver our services. By using our services, you agree to our use of cookies. OK